|
AU2012200031A1
|
|
Transmucosal administration of drug compositions for treating and preventing disorders in animals
|
|
JP2009149675A
|
|
Polar or nonpolar buccal spray or capsule
|
|
JP2009079060A
|
|
Polar or non-polar buccal spray or capsule
|
|
CN101801346A
|
|
anti-insomnia compositions and methods
|
|
CA2673049A1
|
|
Stable anti-nausea oral spray formulations and methods
|
|
CA2659245A1
|
|
Anti-migraine oral spray formulations and methods
|
|
CA2649895A1
|
|
Stable hydroalcoholic oral spray formulations and methods
|
|
US2007048229A1
|
|
Buccal, polar and non-polar spray containing atropine
|
|
US2006210484A1
|
|
Buccal, polar and non-polar spray containing testosterone
|
|
WO2005032517A1
|
|
Buccal, polar and non-polar spray containing diazepam
|
|
CA2554954A1
|
|
Buccal, polar and non-polar spray containing ondansetron
|
|
CA2581996A1
|
|
Buccal, polar and non-polar spray containing alprazolam
|
|
WO2005032518A1
|
|
Buccal, polar and non-polar spray containing sumatriptan
|
|
US2005002867A1
|
|
Buccal, polar and non-polar sprays containing propofol
|
|
US2004265239A1
|
|
Buccal, polar and non-polar spray containing zolpidem
|
|
WO2004019909A2
|
|
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
|
WO2004019905A1
|
|
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
|
WO2004035021A2
|
|
Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
EP1539097A1
|
|
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
|
EP1444976A1
|
|
Buccal, polar and non-polar spray or capsule
|
